Preprint · OA
via OpenAlex
Identification of novel strategies to radiosensitise tumour cells
Oxford University Research Archive (ORA) (University of Oxford) · 2014
Genomic instability
Disabled macroautophagy
Rapamycin / mTOR inhibition
Cell culture / in vitro
Human
Abstract
In this study we found that tumour cells can be radiosensitised by targeting the DNA damage response kinases, ATM and ATR. Furthermore, we highlight that Wee1 inhibitors, which are already under the clinical trials need to be further investigated in combination with radiation in the context of tumour hypoxia. In addition, we observed that induction of autophagy(definition) using STF-62247 can lead to radiosensitisation of VHL deficient RCC cells. Our studies with the mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) analogue temsirolimus, already in the clinic for the treatment of various cancers, can be a potential candidate as a radiosensitiser for RCC cells. Overall, these finding led us to investigate further whether autophagy inducing compounds, which are either in clinic or in clinical trials, can effect the response to radiation. From a panel of candidate drugs which are known to induce autophagy we identified an aminopeptidase inhibitor, CHR-2797. CHR-2797 induces autophagy in the oesophageal cancer cell lines FLO-1 and OE21. Although, our results with CHR-2797 demonstrate it as a potential radiosensitiser, the mechanism of its radiosensitisation needs to be established. Our results from CHR-2797-induced radiosensitisation, further led us to investigate if other aminopeptidase inhibitors have a role in radiosensitisation. Therefore, we selectively screened candidate aminopeptidase inhibitors and identified some promising effects on radiosensitivity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5287/ora-orv9b7ndm
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anbalagan, S. (2014). Identification of novel strategies to radiosensitise tumour cells. <em>Oxford University Research Archive (ORA) (University of Oxford)</em>. https://doi.org/10.5287/ora-orv9b7ndm
Vancouver
Anbalagan S. Identification of novel strategies to radiosensitise tumour cells. Oxford University Research Archive (ORA) (University of Oxford). 2014. doi:10.5287/ora-orv9b7ndm.
BibTeX
@unpublished{selvakumar2014Identi,
title = {Identification of novel strategies to radiosensitise tumour cells},
author = {Selvakumar Anbalagan},
journal = {Oxford University Research Archive (ORA) (University of Oxford)},
year = {2014},
doi = {10.5287/ora-orv9b7ndm},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2012
Open access · CC-BY
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
The Journal of Cardiovascular Aging 2023
Open access · CC-BY
Senolytics rejuvenate the reparative activity of human cardiomyocytes and endothelial cells
Diseases 2023
Open access · CC-BY
Protein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response
Aging 2023
Open access · CC-BY
Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic
Cancer Prevention Research 2011
Open access · OA
Role of Autophagy in Cancer Prevention
Oncology Letters 2016
Open access · CC-BY